Skip to main content

Researcher at the Department of Immunotechnology presents on the clinical utility of protein modifications (PTMs) at the inaugural Chaperone Code Symposium

– Published 23 October 2020

Doctor Magnus Jakobsson will present his work 28.10.2020 on the enzymology and clinical relevance of post‑translational modifications (PTM) of the universally conserved protein Hsp70. His work has uncovered the human enzyme METTL21A (Uniprotein ID: Q8WXB1) as a specific methyltransferase targeting Lys561 in Hsp70 and demonstrated the value of this PTM as a prognostic biomarker for high grade serous ovarian cancer. 

Website of the International Symposium on the Chaperone Code: